The largest database of trusted experimental protocols

Rage antagonist peptide rap

Manufactured by Merck Group

The RAGE antagonist peptide (RAP) is a laboratory reagent used in research applications. It functions as an antagonist to the receptor for advanced glycation end products (RAGE), a cell surface receptor involved in various cellular processes. RAP can be utilized in experimental studies to investigate the role of RAGE signaling. No further details on intended use are provided.

Automatically generated - may contain errors

2 protocols using rage antagonist peptide rap

1

Quantifying Cell Death and Cytokine Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess cell death and IL-1β secretion, cells were primed with IFN-γ (10 ng/mL; R&D Systems) and Pam3CSK4 (0.5 μg/mL; InvivoGen) for 3 h and stimulated with 1 μg LPS or transfected with LPS (1 μg)-Lipofectamine 2000 (Invitrogen). Supernatants were collected 16 h post-stimulation and cell death was measured by LDH release. IL-1β levels in the supernatant was measured by ELISA. To visualize LPS internalization, BMDMs were stimulated with FITC-LPS (100 ng/mL) or FITC-LPS pre-incubated with recombinant HMGB1 (400 ng/mL) for 20 min at room temperature as described previously (Deng et al., 2018 (link)). RAGE-mediated FITC-LPS internalization was assessed by treating BMDMs with DMSO or RAGE inhibitors (1 μM FPS-ZM1 (Cayman), or 10 μM RAGE antagonist peptide (RAP; Millipore) (Deng et al., 2018 (link); Senatus et al., 2020 )) 1 h before LPS treatment. Cells were washed with PBS 2 h later, fixed, permeabilized, and blocked as described above and stained with antibodies against FITC and CD45.
+ Open protocol
+ Expand
2

Quantifying Cell Death and Cytokine Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess cell death and IL-1β secretion, cells were primed with IFN-γ (10 ng/mL; R&D Systems) and Pam3CSK4 (0.5 μg/mL; InvivoGen) for 3 h and stimulated with 1 μg LPS or transfected with LPS (1 μg)-Lipofectamine 2000 (Invitrogen). Supernatants were collected 16 h post-stimulation and cell death was measured by LDH release. IL-1β levels in the supernatant was measured by ELISA. To visualize LPS internalization, BMDMs were stimulated with FITC-LPS (100 ng/mL) or FITC-LPS pre-incubated with recombinant HMGB1 (400 ng/mL) for 20 min at room temperature as described previously (Deng et al., 2018 (link)). RAGE-mediated FITC-LPS internalization was assessed by treating BMDMs with DMSO or RAGE inhibitors (1 μM FPS-ZM1 (Cayman), or 10 μM RAGE antagonist peptide (RAP; Millipore) (Deng et al., 2018 (link); Senatus et al., 2020 )) 1 h before LPS treatment. Cells were washed with PBS 2 h later, fixed, permeabilized, and blocked as described above and stained with antibodies against FITC and CD45.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!